UBS AM’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-173,438
| Closed | -$711K | – | 2831 |
|
|
2022
Q1 | $711K | Buy |
173,438
+2,283
| +1% | +$9.36K | ﹤0.01% | 2306 |
|
|
2021
Q4 | $611K | Buy |
171,155
+3,555
| +2% | +$12.7K | ﹤0.01% | 2469 |
|
|
2021
Q3 | $610K | Buy |
167,600
+1,730
| +1% | +$6.3K | ﹤0.01% | 2415 |
|
|
2021
Q2 | $723K | Buy |
165,870
+918
| +0.6% | +$4K | ﹤0.01% | 2380 |
|
|
2021
Q1 | $678K | Buy |
164,952
+8,800
| +6% | +$36.2K | ﹤0.01% | 2271 |
|
|
2020
Q4 | $623K | Hold |
156,152
| – | – | ﹤0.01% | 2213 |
|
|
2020
Q3 | $422K | Hold |
156,152
| – | – | ﹤0.01% | 2205 |
|
|
2020
Q2 | $429K | Sell |
156,152
-15,267
| -9% | -$42K | ﹤0.01% | 2179 |
|
|
2020
Q1 | $405K | Buy |
171,419
+10,203
| +6% | +$24.1K | ﹤0.01% | 2057 |
|
|
2019
Q4 | $758K | Buy |
161,216
+56,451
| +54% | +$265K | ﹤0.01% | 2055 |
|
|
2019
Q3 | $350K | Buy |
104,765
+54,681
| +109% | +$183K | ﹤0.01% | 2403 |
|
|
2019
Q2 | $165K | Hold |
50,084
| – | – | ﹤0.01% | 2581 |
|
|
2019
Q1 | $152K | Buy |
50,084
+4,900
| +11% | +$14.8K | ﹤0.01% | 2525 |
|
|
2018
Q4 | $123K | Buy |
+45,184
| New | +$123K | ﹤0.01% | 2495 |
|
|
2015
Q4 | – | Sell |
-63,096
| Closed | -$107K | – | 2725 |
|
|
2015
Q3 | $107K | Hold |
63,096
| – | – | ﹤0.01% | 2605 |
|
|
2015
Q2 | $131K | Buy |
63,096
+3,500
| +6% | +$7.27K | ﹤0.01% | 2650 |
|
|
2015
Q1 | $162K | Buy |
59,596
+3,700
| +7% | +$10.1K | ﹤0.01% | 2527 |
|
|
2014
Q4 | $144K | Hold |
55,896
| – | – | ﹤0.01% | 2535 |
|
|
2014
Q3 | $102K | Sell |
55,896
-965,400
| -95% | -$1.76M | ﹤0.01% | 2511 |
|
|
2014
Q2 | $2.73M | Sell |
1,021,296
-106,300
| -9% | -$284K | ﹤0.01% | 1207 |
|
|
2014
Q1 | $3.95M | Buy |
1,127,596
+253,300
| +29% | +$887K | ﹤0.01% | 1100 |
|
|
2013
Q4 | $3.92M | Sell |
874,296
-42,000
| -5% | -$188K | ﹤0.01% | 1066 |
|
|
2013
Q3 | $3.72M | Buy |
916,296
+30,100
| +3% | +$122K | ﹤0.01% | 1053 |
|
|
2013
Q2 | $3.69M | Buy |
+886,196
| New | +$3.69M | ﹤0.01% | 1034 |
|